Anteris Technologies Global Corp. (NASDAQ:AVR) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) have received a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $15.3333.

A number of research firms recently weighed in on AVR. Wells Fargo & Company began coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 target price on the stock. Barclays reissued an “overweight” rating on shares of Anteris Technologies Global in a research report on Friday. Lake Street Capital reissued a “buy” rating and set a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, March 27th.

Anteris Technologies Global Trading Up 11.0%

Shares of Anteris Technologies Global stock opened at $7.25 on Friday. The company’s fifty day simple moving average is $5.93 and its 200-day simple moving average is $5.35. The company has a market cap of $705.72 million, a price-to-earnings ratio of -3.25 and a beta of 1.32. Anteris Technologies Global has a 1 year low of $2.85 and a 1 year high of $7.49.

Anteris Technologies Global (NASDAQ:AVR) last released its earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The firm had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.77 million. During the same period last year, the business earned ($0.61) earnings per share. As a group, research analysts forecast that Anteris Technologies Global will post -1.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Anteris Technologies Global

A number of institutional investors have recently bought and sold shares of the business. L1 Capital Pty Ltd boosted its stake in Anteris Technologies Global by 143.2% during the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock worth $30,772,000 after buying an additional 4,026,136 shares in the last quarter. Nantahala Capital Management LLC boosted its stake in Anteris Technologies Global by 31.9% during the fourth quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock worth $12,629,000 after buying an additional 612,244 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Anteris Technologies Global by 32.7% during the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock valued at $6,379,000 after purchasing an additional 349,299 shares in the last quarter. ADAR1 Capital Management LLC boosted its holdings in Anteris Technologies Global by 526.9% during the fourth quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company’s stock valued at $6,181,000 after purchasing an additional 1,041,162 shares in the last quarter. Finally, Affinity Asset Advisors LLC boosted its holdings in Anteris Technologies Global by 87.5% during the first quarter. Affinity Asset Advisors LLC now owns 912,397 shares of the company’s stock valued at $5,064,000 after purchasing an additional 425,713 shares in the last quarter.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.